Drug Shortage Report for SANDOZ LISINOPRIL HCT
Report ID | 224639 |
Drug Identification Number | 02302381 |
Brand name | SANDOZ LISINOPRIL HCT |
Common or Proper name | LISINOPRIL HCT |
Company Name | SANDOZ CANADA INCORPORATED |
Market Status | MARKETED |
Active Ingredient(s) | HYDROCHLOROTHIAZIDE LISINOPRIL |
Strength(s) | 25MG 20MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 30TAB |
ATC code | C09BA |
ATC description | ACE INHIBITORS, COMBINATIONS |
Reason for shortage | Shortage of an active ingredient. |
Anticipated start date | |
Actual start date | 2024-04-08 |
Estimated end date | 2025-03-07 |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2024-12-02 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v7 | 2024-12-02 | French | Compare |
v6 | 2024-12-02 | English | Compare |
v5 | 2024-11-18 | French | Compare |
v4 | 2024-11-18 | English | Compare |
v3 | 2024-04-09 | English | Compare |
v2 | 2024-04-08 | French | Compare |
v1 | 2024-04-08 | English | Compare |
Showing 1 to 7 of 7